[1]
D. N. . Desai, “Advances in Controlled Drug Delivery Systems: Formulation Strategies, Nanostructured Lipid Carriers, and Therapeutic Implications with Special Reference to Ziprasidone”, fmspj, vol. 6, no. 03, pp. 20–30, Mar. 2026.